Steven Halper
Stock Analyst at Cantor Fitzgerald
(3.04)
# 1,358
Out of 4,711 analysts
72
Total ratings
51.67%
Success rate
8.98%
Average return
Main Sectors:
Stocks Rated by Steven Halper
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NYXH Nyxoah | Reiterates: Overweight | $11 | $8.01 | +37.33% | 5 | Sep 26, 2023 | |
| NNOX Nano-X Imaging | Reiterates: Overweight | $30 | $6.76 | +343.79% | 11 | Sep 26, 2023 | |
| HCAT Health Catalyst | Reiterates: Overweight | $16 | $7.09 | +125.67% | 4 | Sep 14, 2023 | |
| AMWL American Well | Initiates: Overweight | $300 | $7.87 | +3,711.94% | 1 | Sep 14, 2021 | |
| HQY HealthEquity | Maintains: Overweight | $82 → $85 | $94.95 | -10.48% | 10 | Jun 8, 2021 | |
| OMCL Omnicell | Downgrades: Neutral | n/a | $44.98 | - | 7 | Dec 3, 2020 | |
| ROOT Root, Inc. | Initiates: Overweight | $504 | $73.22 | +588.34% | 1 | Nov 23, 2020 | |
| GOCO GoHealth | Initiates: Overweight | $390 | $12.78 | +2,951.64% | 1 | Aug 10, 2020 | |
| EVH Evolent Health | Downgrades: Neutral | $9 → $8 | $11.41 | -29.89% | 6 | Jun 2, 2020 | |
| TDOC Teladoc Health | Maintains: Neutral | $135 → $145 | $9.44 | +1,436.02% | 8 | Apr 15, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $150 → $185 | $8.32 | +2,123.56% | 5 | Feb 21, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $245 → $255 | $276.92 | -7.92% | 2 | Feb 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $345 → $400 | $247.10 | +61.88% | 2 | Feb 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $32 | $25.16 | +27.19% | 1 | Jan 9, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $73 → $83 | $59.58 | +38.47% | 8 | Dec 17, 2018 |
Nyxoah
Sep 26, 2023
Reiterates: Overweight
Price Target: $11
Current: $8.01
Upside: +37.33%
Nano-X Imaging
Sep 26, 2023
Reiterates: Overweight
Price Target: $30
Current: $6.76
Upside: +343.79%
Health Catalyst
Sep 14, 2023
Reiterates: Overweight
Price Target: $16
Current: $7.09
Upside: +125.67%
American Well
Sep 14, 2021
Initiates: Overweight
Price Target: $300
Current: $7.87
Upside: +3,711.94%
HealthEquity
Jun 8, 2021
Maintains: Overweight
Price Target: $82 → $85
Current: $94.95
Upside: -10.48%
Omnicell
Dec 3, 2020
Downgrades: Neutral
Price Target: n/a
Current: $44.98
Upside: -
Root, Inc.
Nov 23, 2020
Initiates: Overweight
Price Target: $504
Current: $73.22
Upside: +588.34%
GoHealth
Aug 10, 2020
Initiates: Overweight
Price Target: $390
Current: $12.78
Upside: +2,951.64%
Evolent Health
Jun 2, 2020
Downgrades: Neutral
Price Target: $9 → $8
Current: $11.41
Upside: -29.89%
Teladoc Health
Apr 15, 2020
Maintains: Neutral
Price Target: $135 → $145
Current: $9.44
Upside: +1,436.02%
Feb 21, 2020
Reiterates: Overweight
Price Target: $150 → $185
Current: $8.32
Upside: +2,123.56%
Feb 6, 2020
Reiterates: Overweight
Price Target: $245 → $255
Current: $276.92
Upside: -7.92%
Feb 5, 2020
Reiterates: Overweight
Price Target: $345 → $400
Current: $247.10
Upside: +61.88%
Jan 9, 2020
Initiates: Overweight
Price Target: $32
Current: $25.16
Upside: +27.19%
Dec 17, 2018
Maintains: Overweight
Price Target: $73 → $83
Current: $59.58
Upside: +38.47%